Sepsis Diagnosis and Treatment · Journal article
Scientific Reports · September 4, 2026
Early or partial results. Treat as a signal, not a conclusion.
In a retrospective cohort of 658 septic oncology ICU patients, restrictive and liberal transfusion practices showed no significant difference in 28- or 90-day mortality after propensity score adjustment, though unadjusted analysis favored the liberal group. Restrictive practice was associated with increased acute kidney injury; however, causality cannot be established from observational data and the authors explicitly caution against causal interpretation.
Retrospective, non-randomized cohort study with propensity score analysis. Oncologic patients with sepsis admitted to ICU between 2014 and 2023. Patients with mixed or unclassifiable transfusion practices were excluded.. Intervention: Restrictive transfusion practice (hemoglobin threshold < 7–8 g/dL for transfusion decision). Compared with: Liberal transfusion practice (hemoglobin threshold ≤ 9–10 g/dL for transfusion decision). n = 658.
Unadjusted analysis showed higher 90-day mortality in restrictive group, but association was not significant after IPTW adjustment No difference in 28-day mortality observed between restrictive and liberal transfusion groups Restrictive transfusion practice associated with increased risk of acute kidney injury compared to liberal practice, association remained significant after clinical adjustment
No confidence intervals or p-values reported for primary mortality outcomes Unadjusted analysis showed higher 90-day mortality in restrictive group, but association was not significant after IPTW adjustment
These findings suggest that restrictive versus liberal transfusion strategy does not meaningfully alter mortality in septic oncology ICU patients after accounting for baseline differences. The association with renal injury in the restrictive group should prompt prospective evaluation but cannot guide practice change based on this observational evidence alone.
Retrospective, non-randomized study with acknowledged selection bias and baseline imbalances; propensity score adjustment did not find mortality difference, but renal injury association lacks causal evidence and requires prospective confirmation.
As stated by the source record.
Quoted from the source exactly as published.
These findings suggest that restrictive versus liberal transfusion strategy does not meaningfully alter mortality in septic oncology ICU patients after accounting for baseline differences. The association with renal injury in the restrictive group should prompt prospective evaluation but cannot guide practice change based on this observational evidence alone.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Red blood cell (RBC) transfusion is a commonly utilized supportive therapy in intensive care units (ICUs). However, the optimal transfusion practice in oncologic patients with sepsis remains controversial. This study aimed to compare the clinical outcomes of liberal versus restrictive transfusion practices in oncologic patients with sepsis admitted to the ICU. This retrospective, non-randomized study included oncologic patients with sepsis admitted to the ICU between 2014 and 2023. Patients were classified as having restrictive or liberal transfusion practice based on serial hemoglobin (Hb) measurements and corresponding decisions to administer or withhold RBC transfusion, reflecting lower (< 7–8 g/dL) or higher (≤ 9–10 g/dL) Hb thresholds, respectively. Among patients who did not receive RBC transfusion, withholding transfusion at Hb levels of 7.1–8.9 g/dL and 9.1–10.0 g/dL was classified as restrictive and liberal transfusion practice, respectively; thus, actual receipt of RBC transfusion was not required for group assignment. Patients with mixed or otherwise unclassifiable transfusion practices were excluded. As treatment decisions were determined by treating physicians, the approach may introduce selection bias. Demographic characteristics, clinical scores, primary tumor type, laboratory parameters, organ dysfunction, infection characteristics, and mortality outcomes were compared. Descriptive statistics were calculated. Propensity score analysis with stabilized inverse probability of treatment weighting (IPTW) was used to minimize confounding and selection bias. Logistic regression models were used to evaluate associations between transfusion practice and binary outcomes, and Cox proportional hazards models were used to assess survival. A total of 658 patients were included. Baseline severity scores were higher in the restrictive transfusion group, as reflected by significantly greater Acute Physiology and Chronic Health Evaluation (APACHE) II and Sequential Organ Failure Assessment (SOFA) scores. There was a marked imbalance in primary tumor type’s distribution between groups, with lung cancer more frequent in the liberal group and gastrointestinal malignancies predominating in the restrictive group. Overall organ dysfunction rates were similar between groups; however, acute kidney injury occurred more frequently in the restrictive group. No differences were observed in duration of mechanical ventilation, use of vasopressors, or requirement for renal replacement therapy. Unadjusted analysis suggested higher 90-day mortality in the restrictive group, but this association was not significant after IPTW adjustment. No difference in 28-day mortality was observed. The restrictive transfusion group was associated with an increased risk of renal injury compared to the liberal transfusion group, and this association remained significant after clinical adjustment. In critically ill patients with sepsis and malignancy, restrictive and liberal transfusion practices were not associated with significant differences in mortality after IPTW adjustment. The observed association between restrictive transfusion practice and renal injury should be interpreted cautiously, as it does not establish a causal relationship. Prospective studies evaluating individualized transfusion practices are warranted.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.